Pharmaceuticals/Chemicals
Metformin (Immediate Release)
Also called Glucophage · Metformin HCl · Metformin hydrochloride · Metformin IR
Bodybuilders discuss metformin to keep blood sugar in check during high-carb bulks or GH use, hoping better insulin sensitivity will help them gain muscle with less fat. The practical questions are whether glucose actually improves, whether digestion suffers, and whether training gains are affected. This entry covers immediate-release tablets.
Dosage & duration
U.S. immediate-release label: adults with type 2 diabetes
Labeled starting options
Product label- Dose
- 500 mg or 850 mg
- How often
- 500 mg twice daily OR 850 mg once daily, with meals
- How long
- Ongoing treatment, reviewed by glucose response and tolerability
These are alternative labeled starting schedules. They do not describe a longevity or bodybuilding protocol.
Sources: 1
The plot’s 500 mg example uses immediate-release study data. ER/XR is a different formulation, and dose changes are not a precise linear exposure conversion.
During a bulk
Lower glucose does not prove a leaner bulk
-
Glucose control
Glucose and HbA1c trends answer the blood-sugar question.
-
Physique progress
Weight, waist and body composition describe a different outcome.
-
Training and digestion
Workout progress and stomach symptoms matter alongside the lab result.
Why does metformin come up during a bulk?
In the bodybuilding discussions reviewed, the goal is to keep glucose under control while eating more carbohydrates, particularly when GH is involved. Some users also hope for better “nutrient partitioning”—more of the gained weight being muscle rather than fat. Those are related motivations, but they are not the same result.
Does it make a bulk leaner?
Metformin has an established glucose-lowering role. A claim that it lets someone eat more without gaining fat is a much bigger step. In reported experiences, food intake, GH, other drugs and training may change together, so a leaner look cannot be assigned to metformin alone. Keep glucose improvement and physique progress as separate questions.
Will it interfere with gains or workouts?
This is a genuine point of disagreement among users: some report no difference, while others mention feeling flatter or training less well. The MASTERS trial found less muscle gain with metformin during resistance training in healthy adults aged 65 and older. It does not answer the question in young enhanced lifters, or prove that moving tablets away from workouts avoids the effect.
IR, ER and keeping meals comfortable
Gas, nausea and diarrhea can matter when eating enough is already difficult. IR and ER release the drug differently, which is why the product matters in both the dose guide and the plot. The visible doses are label context, not a carb-to-metformin formula. Kidney function and B12 remain part of ongoing clinical follow-up. Reduced kidney function increases the risk of serious lactic acidosis.
Model details: Metformin (Immediate Release) · estimated
How to read this estimate
Estimated from study endpoints; the curve between measurements is reconstructed. Compare amounts and timing in mg.
Immediate-release tablet estimate in healthy adults; it does not represent extended-release metformin or blood glucose.
Assumptions, calculation and sources
Single 500 mg Glucophage immediate-release tablet, Nordic Laboratories (Canada); food state not specified in the accessible study abstract. Oral. 24 young healthy volunteers in Caille et al. 1993.
metformin parent: estimated concentration in plasma (mcg/mL).
Caille 1993 single 500 mg tablet study; the 3.16 h plasma half-life belongs to that study, not the longer whole-blood half-life.
- Calibration dose
- 500 mg
- Reported calibration peak
- 0.6821 mcg/mL
- Peak timing used
- 2.4 hours
- Terminal half-life used
- 3.16 hours
- Reconstructed absorption rate
- 0.7070012 /hour
- Reconstructs first-order absorption from the reported peak, peak time and terminal half-life; this is not the authors’ fitted model.
- Input is the nominal metformin hydrochloride tablet strength used by the study. No salt-mass conversion or additional bioavailability factor is applied.
- Fixed parameters and linear dose scaling are mathematical approximations. The current label reports less-than-proportional absorption as doses increase.
- Repeated-dose superposition uses the same fixed parameters; food, kidney function and transporter interactions are not personalized.
- The accessible original abstract reports Cmax, Tmax and half-life but not AUC or meal conditions; total-exposure fit could not be verified against that study.
- The reconstructed AUC to infinity is 5.2643 mcg·h/mL at 500 mg. This is a model output, not an observed AUC.
- Plasma persistence differs from whole-blood persistence and duration of glucose lowering. This model does not estimate HbA1c, lifespan, exercise adaptations or a safe concentration.
- Caille et al. 1993 — single-dose metformin tablet pharmacokinetics
Original indexed abstract: 24 young healthy volunteers, single 500 mg Glucophage tablet (Nordic Laboratories, Canada); plasma Cmax 682.1 ng/mL, Tmax 2.4 h, half-life 3.16 h; sampling to 30 h. Food state and AUC were not available in the accessible abstract. DOI 10.1002/bdd.2510140308.
- DailyMed — metformin immediate-release prescribing information (July 2026)
Sections 1, 2.1, 2.3, 5.1–5.3 and 12.3: type 2 diabetes; adult starting doses; renal assessment, lactic acidosis and B12; nonlinear absorption and plasma versus whole-blood timing. These label timings do not calibrate the selected study curve.
Estimate metformin-ir-caille-1993-estimate · version 1
Common questions
Why do bodybuilders discuss metformin with GH?
The discussions reviewed focus on glucose readings rising during GH use and high-food-intake phases. Users hope metformin will improve glucose control and help keep a bulk lean. That describes the motivation; it does not establish automatic protection from GH-related problems.
Is metformin a nutrient-partitioning drug?
Bodybuilding discussions use that phrase to mean directing more of a surplus toward muscle rather than fat. Metformin treats glucose control, but that does not establish a predictable muscle-to-fat advantage during a bulk.
Metformin or berberine: which is better for a bulk?
Users compare cost, digestion and glucose readings, but personal accounts do not establish a reliable winner for muscle gain or a dose conversion between them. They are different substances; a personal response report is not a head-to-head trial.
Can taking it only on rest days avoid effects on gains?
That is discussed online, but the reviewed evidence does not establish a rest-day schedule that preserves muscle growth. Do not treat the drug-level curve as a way to find a guaranteed workaround.
Is 500 mg once daily the usual metformin starting dose?
That depends on the formulation and treatment plan. The cited U.S. adult IR label starts at 500 mg twice daily or 850 mg once daily with meals. A common ER label starts at 500 mg once daily with the evening meal. These are different products, not interchangeable timing curves.
Can I plot extended-release metformin here?
This entry represents an immediate-release tablet study. Entering an ER dose into it does not turn it into an ER model.
Sources Labels, studies and notes behind this guide
Catalog evidence: Human clinical trials. This describes the type of evidence, not a clinical review of every claim.
Summary and fact source checks: 2026-10-09. This records source checking, not medical review of the whole page.
Notes on the quick facts
- Why lifters look at it
- Some lifters consider it for rising fasting glucose, especially alongside GH and high food intake.
- Hoped-for payoff
- Better glucose numbers and gaining less fat are separate outcomes; personal accounts may blur them.
- Practical trade-off
- Stomach symptoms are common; lifters also debate pumps, workout quality and muscle gains.
- 1. DailyMed — metformin immediate-release prescribing information (July 2026)
Sections 1, 2.1, 2.3, 5.1–5.3 and 12.3: type 2 diabetes; adult starting doses; renal assessment, lactic acidosis and B12; nonlinear absorption and plasma versus whole-blood timing. These label timings do not calibrate the selected study curve.
- 2. Walton et al. 2019 — MASTERS randomized trial
94 healthy adults aged at least 65 completed 14 weeks of resistance training with 1700 mg/day metformin or placebo; metformin group gained less lean and thigh muscle mass. This is not a result in young PED users and does not establish an exercise-day workaround.
- 3. Caille et al. 1993 — single-dose metformin tablet pharmacokinetics
Original indexed abstract: 24 young healthy volunteers, single 500 mg Glucophage tablet (Nordic Laboratories, Canada); plasma Cmax 682.1 ng/mL, Tmax 2.4 h, half-life 3.16 h; sampling to 30 h. Food state and AUC were not available in the accessible abstract. DOI 10.1002/bdd.2510140308.
- 4. DailyMed — metformin extended-release tablet label
Formulation comparison only: matrix extended-release tablets, usual starting dose 500 mg with the evening meal, median Tmax 7 h (4–8 h). Not the plotted formulation.
Related compounds and examples
Related compounds
Empagliflozin (Jardiance)
Why bodybuilders discuss Jardiance: glucose during GH use, water-weight and cutting hopes, metformin comparisons, and questions about carbs, fullness and hydration.
Estradiol Topical (EstroGel)
Estradiol gel is used to ease menopausal hot flushes and other low-estrogen symptoms without a pill or injection. The practical choices are the exact pump product, the daily skin routine and whether a separate progestogen is needed.
Estradiol Cypionate
Estradiol cypionate provides estrogen through an injection rather than a daily pill or gel. It is used for low-estrogen symptoms and in feminizing hormone care; the reason for treatment determines the dose and schedule.